News & Events Media Coverage

Media Coverage of CTI's COVID-19 Work

June 4, 2020

CTI - One of Founding Contributers of NKY Coronavirus Emergency Relief Fund

CTI is proud to be one of othe original contributers to a local relief fund for those affected by the pandemic. 

Coverage by the NKY Tribune

Coverage by The Lane Report

Coverage by the Cincinnati Enquirer

Coverage by Soapbox Cincinnati

Coverage by the NKY Tribune

Coverage by the NKY Tribune

Coverage by Fox 19

 

CTI Partners with Humanigen for Phase III Study of Lenzilumab for Treatment of Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients

CTI has partnered with Humanigen to study the use of the biotech's monoclonal antibody, lenzilumab, to treat acute respiratory distress syndrome (ARDS) in COVID-19 patients.

Original press release

Coverage by the Cincinnati Business Courier

Coverage by the NKY Tribune

Coverage by Proactive Investors

 

CTI Partners with Pulmotect on Two Phase II Trials Targeting COVID-19

Pulmotect Press Release

CTI Press Release

 

Xavier Alum's Company Testing Drug to Treat COVID-19 Patients

Xavier University published a highlight of university alumni who are working to combat COVID-19. Tim Schroeder is one of those alumni.

Read the story here.

 

FDA Approves Initiation of Humanigen’s Phase III Study of Lenzilumab in COVID-19 Patients

CTI's Phase III program with Humanigen was approved by the FDA.

Original press release

Coverage by Yahoo Finance 

Coverage by Stock Day Media

 

First Patient Dosed in Humanigen's Phase III Study of Lenzilumab in COVID-19 Patients

Original Press Release

Coverage by Proactive Investors

Coverage by Yahoo Finance

Coverage by NKY Thrives

 

CTI Partners with St. Elizabeth Healthcare and Pulmotect to Open First Hospital Site for Phase II Clinical Trial Targeting COVID-19

Original Press Release

Coverage by Local 12 News

Coverage by Cincinnati Business Courier

The Cincinnati Enquirer

Coverage by WCPO News

Coverage by MSN

Coverage by WLWT

Coverage by The River City News

Coverage by the NKY Tribune

Coverage by PR Newswire

Coverage by BioSpace

Coverage by NKY Thrives

 

Cincinnati Chamber COVID-19 Business Briefing "Viruses, Vectors and Vaccines: The Pathways to Prevention and a Cure"

Watch the video here.

 

CTI CEO Speaks with Kenton County Judge/Executive on COVID-19

Watch the video here.

 

CTI CEO Speaks at Covington Business Council's 'virtual luncheon' on COVID-19

Watch the video here.

Coverage by the NKY Tribune

 

CTI CEO Speaks With Local Company, Horan, About Progress Made in COVID-19 Treatments and Vaccines

Listen to the video here.

 

CTI Seeks 10,000 Volunteers for Local COVID-19 Vaccine Trials

Coverage by Cincinnati Business Courier

Coverage by Local 12 News

 

Op-Ed: Our Region Can Make COVID-19 Vaccine Happen

Coverage by The Lane Report

Coverage by the River City News

 

Miscellaneous Mentions

Coverage by Local 12 News

Coverage by Spectrum News 1 Kentucky

Coverage by Local 12 News

Subscribe to our mailing list

* indicates required